insights_auto
Why is CBIO down 2,65%?
Dive Deeperchevron_right
CBIO:NASDAQ
Crescent Biopharma Inc
US$13,57
arrow_downward
-2,65%(-0,37) 1D
US$13,57
0,00% (0,00)
bedtimeAfter hours
Closed: 6 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CBIO...
Open
US$14,78
High
US$14,93
Low
US$13,46
Mkt. cap
517,78 ລ້ານ
Avg. vol.
451,70 ພັນ
Volume
0,00
52-wk high
US$27,41
52-wk low
US$8,72
EPS
US$-7,41
Beta
1,27
Shares outstanding
37,14 ລ້ານ
No. of employees
69
Open
US$14,78
High
US$14,93
Low
US$13,46
Mkt. cap
517,78 ລ້ານ
Avg. vol.
451,70 ພັນ
Volume
0,00
52-wk high
US$27,41
52-wk low
US$8,72
EPS
US$-7,41
Beta
1,27
Shares outstanding
37,14 ລ້ານ
No. of employees
69
News stories
From web sources and news partners
Stock Titan
·
11 ຊົ່ວໂມງກ່ອນ
Six employees can buy Crescent shares for $13.94 each once their options vest.
Investing.com
·
18 ຊົ່ວໂມງກ່ອນ
Stifel reiterates Buy on Crescent Biopharma stock, $28 target
Investing.com
·
19 ຊົ່ວໂມງກ່ອນ
Crescent Biopharma stock rating upgraded to buy at H.C. Wainwright
Stock Titan
·
1 ມື້ກ່ອນ
The FDA clears an application to test Crescent’s cancer treatment in people.
About Crescent Biopharma Inc
CEO-
Employees69
Founded2024
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websitecrescentbiopharma.com